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Introduction
Cardiovascular disease is the leading cause of mortality and 
morbidity in industrialized nations. Since the discovery of the first 
key determinant of heart development—tinman—in Drosophila 
(Azpiazu and Frasch, 1993; Bodmer, 1993), numerous regula-
tors, including transcription factors, cell signaling molecules, 
extracellular matrix proteins, and microRNAs have provided an 
understanding of an increasingly complex network that guides 
cardiac specification, differentiation, function, and maturation 
in all organisms that possess a heart (Bier and Bodmer, 2004; 
Olson, 2006; Srivastava, 2006; Qian et al., 2008a).
The fruit fly Drosophila is an attractive model system to 
study  various  human  diseases,  including  cardiac  disease   
(St Johnston, 2002; Bier, 2005). The Drosophila heart is a 
simple linear tube comprised of myocardial and pericardial cells, 
which is reminiscent of the primitive vertebrate embryonic heart. 
U
nraveling the gene regulatory networks that gov-
ern development and function of the mammalian 
heart is critical for the rational design of thera-
peutic interventions in human heart disease. Using the 
Drosophila heart as a platform for identifying novel gene 
interactions leading to heart disease, we found that the 
Rho-GTPase Cdc42 cooperates with the cardiac transcrip-
tion factor Tinman/Nkx2-5. Compound Cdc42, tinman 
heterozygous mutant flies exhibited impaired cardiac out-
put and altered myofibrillar architecture, and adult heart–
specific interference with Cdc42 function is sufficient to 
cause these same defects. We also identified K
+ channels, 
encoded by dSUR and slowpoke, as potential effectors of 
the Cdc42–Tinman interaction. To determine whether a 
Cdc42–Nkx2-5 interaction is conserved in the mamma-
lian heart, we examined compound heterozygous mutant 
mice and found conduction system and cardiac output   
defects. In exploring the mechanism of Nkx2-5 interaction 
with Cdc42, we demonstrated that mouse Cdc42 was a 
target of, and negatively regulated by miR-1, which itself 
was negatively regulated by Nkx2-5 in the mouse heart 
and by Tinman in the fly heart. We conclude that Cdc42 
plays a conserved role in regulating heart function and is 
an indirect target of Tinman/Nkx2-5 via miR-1.
Tinman/Nkx2-5 acts via miR-1 and upstream of 
Cdc42 to regulate heart function across species
Li Qian,
1,2,3 Joshua D. Wythe,
2,3 Jiandong Liu,
1,4 Jerome Cartry,
1 Georg Vogler,
1 Bhagyalaxmi Mohapatra,
5,12  
Robyn T. Otway,
6 Yu Huang,
2 Isabelle N. King,
2,3 Marjorie Maillet,
14 Yi Zheng,
14 Timothy Crawley,
1  
Ouarda Taghli-Lamallem,
1 Christopher Semsarian,
10 Sally Dunwoodie,
7,8 David Winlaw,
11 Richard P. Harvey,
7,8  
Diane Fatkin,
6,8,9 Jeffrey A. Towbin,
5,13 Jeffery D. Molkentin,
14 Deepak Srivastava,
2,3 Karen Ocorr,
1  
Benoit G. Bruneau,
2,3 and Rolf Bodmer
1
1Development and Aging Program, NASCR Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037
2Gladstone Institute for Cardiovascular Disease, 
3Department of Pediatrics and Cardiovascular Research Institute, and 
4Department of Biochemistry and Biophysics, 
University of California, San Francisco, San Francisco, CA 94158
5Pediatric Cardiology, Baylor College of Medicine, Texas Children’s Hospital, Houston, TX 77030
6Division of Molecular Cardiology, 
7Division of Developmental Biology, Victor Chang Cardiac Research Institute, 
8Faculty of Medicine, and 
9St. Vincent’s Hospital, 
University of New South Wales, Sydney, Australia
10Department of Cardiology, Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, Faculty of Medicine, Royal Prince Alfred Hospital, University of Sydney, 
Sydney NSW 2006, Australia
11Adolph Basser Cardiac Research and Kids Heart Research, Children’s Hospital at Westmead, Faculty of Medicine, University of Sydney, Sydney, Australia
12Department of Zoology, BHU, Varanasi-221005, India
13Pediatric Cardiology and 
14Molecular Cardiovascular Biology, The Heart Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229
©  2011  Qian  et  al.  This  article  is  distributed  under  the  terms  of  an  Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub-
lication date (see http://www.rupress.org/terms). After six months it is available under a 
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, 
as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
YJCB • VOLUME 193 • NUMBER 7 • 2011   1182
Results
Genetic interactions between Cdc42 and 
tinman in regulating heart performance  
in Drosophila
Increasing  evidence  suggests  that  the  conserved  cardiogenic 
transcription factor network that regulates heart formation also 
functions to establish and maintain cardiac performance in the 
adult (Zaffran et al., 2006; Ocorr et al., 2007; Qian et al., 2008b; 
Qian and Bodmer, 2009). To uncover genes that interact with this 
transcription factor network in adult heart function, we con-
ducted a screen for mutations that aggravate the cardiac stress 
response of flies heterozygous for tinman. We examined cardiac 
performance of double-heterozygous flies for tinman and defi-
ciency lines (97 in total) covering the X chromosome and part of 
the second chromosome (34% of the genome, see Table S1). We 
identified several categories of candidate genes suggestive of a 
developmental interaction: for example, the trans configuration 
of tinman with the deficiency line 7783 is lethal (Fig. 1 A, group II 
bottom), possibly due to a vital interaction with the dpp gene 
(contained within 7783) that is critically involved in cardiac in-
duction during early embryogenesis, along with tinman (Qian   
et al., 2008a). In another category, the heterozygous candidate 
lines by themselves exhibit cardiac defects (increased pacing- 
induced heart failure rate, see Materials and methods; e.g., lines 
7708 and 7499; Fig. 1 A, group I), indicating that haploinsuffi-
ciency in one or more genes covered by these deficiencies results 
in cardiac deficits. Of particular interest, the “strong enhancer” 
category of deficiency lines shows an interaction when in trans 
with tinman (>50%), but when crossed to wild type (w
1118) ex-
hibits a low rate of heart failure (<20%) that is similar to wild-
type flies (e.g., 7717, 7721; Fig. 1 A, group II top). We chose for 
further analysis line 7721, which exhibits a robust interaction 
with tinman, in that the trans combination shows a threefold in-
crease in susceptibility to pacing-induced heart failure (7721 x 
tin
346) compared with single heterozygotes (e.g., 7721 x w
1118).
Among  the  nine  genes  deleted  by  the  deficiency  7721 
(Df(1)Exel6253, referred to as Df(Cdc42)) is the small GTPase 
encoded by Cdc42, which is known for its role in cell cycle regu-
lation and actin cytoskeletal rearrangement (Eaton et al., 1995; 
Genova et al., 2000; Jacinto et al., 2000; Hurd et al., 2003; 
Heasman and Ridley, 2008) and has been implicated in cardio-
myocyte growth and hypertrophy (Carè et al., 2007; Maillet et al., 
2009). We took a candidate gene approach and examined whether 
known Cdc42 loss-of-function mutants also interacted with 
tinman. Both tin
EC40 (Bodmer, 1993) and tin
346 (Azpiazu and 
Frasch, 1993) heterozygotes show a dramatic increase in heart 
failure rate in a Cdc42
3 heterozygous background (Fehon et al., 
1997; Genova et al., 2000), similar to that observed for tinman, 
Df(1)Exel6253 double heterozygotes (Fig. 1 B). This suggests 
that the interaction between tinman and Cdc42 is required for the 
maintenance of proper adult heart function.
Cdc42-encoded RhoGTPase is required for 
adult cardiac function in Drosophila
To examine a possible role for Cdc42 in the fly heart, we asked 
whether Cdc42 plays a muscle- or cardiac-autonomous role. 
Despite the simplicity of the structure, the genetic and mo-
lecular mechanisms that orchestrate heart formation are re-
markably conserved between flies and vertebrates (Bodmer, 
1995; Cripps and Olson, 2002). Moreover, recent studies using 
multiple functional assays revealed extensive conservation of 
gene functions required for maintaining normal heart physiol-
ogy in the adult (Bier and Bodmer, 2004; Ocorr et al., 2007; 
Qian et al., 2008a,b). Combined with the powerful genetic 
tools available in the fly, screens to identify molecular–genetic 
pathways  involved  in  cardiac  contractility  and  rhythm  can 
now be executed, leading to the identification of novel cardiac 
regulators that can then be examined in mammals (Adams 
and Sekelsky, 2002; St Johnston, 2002; Wessells and Bodmer, 
2004; Neely et al., 2010).
Tinman and its mammalian homologue Nkx2-5 are homeo-
box transcription factors that play crucial roles in heart develop-
ment and function (Prall et al., 2002). Whereas ablation of 
tinman in the Drosophila embryo abolishes heart formation,   
targeted deletion of tinman at later stages reveals additional   
requirements for tinman in maintaining normal adult heart func-
tion and physiology (Zaffran et al., 2006). This is reminiscent of 
Nkx2-5 in vertebrates, which is required for establishing heart 
function in the developing mouse embryo, for example, and 
also later for its maintenance in the adult (Pashmforoush et al., 
2004). The genetic networks that Nkx2-5 participates in and 
how these interactions regulate adult heart functions are not 
well understood. A major reason for this is that it is often diffi-
cult to identify and study polygenic modifiers of (cardiac) dis-
ease in a vertebrate system, in part because the organism viability 
is critically dependent on a functional heart.
In a previous study, we identified a genetic interaction   
between neuromancer (nmr)/Tbx20 and tinman/Nkx2-5 in the 
adult Drosophila heart (Qian et al., 2008b). Here, we performed 
a deletion screen in a reduced tinman genetic background to 
identify  genes  that  interact  with  tinman  to  maintain  normal 
heart function in Drosophila. One of the strong genetic interac-
tions causing cardiac dysfunction was between tinman and the 
gene Cdc42, a Rho family member of the small GTPase family, 
suggesting a role for Cdc42 in maintaining heart function.   
Indeed, dominant-negative interference with Cdc42 function alone 
in the adult fly heart compromises cardiac performance. We 
also identified potential downstream effectors of the Cdcd42–
tinman  interaction,  including  dSUR  and  slowpoke,  which 
code for two K
+ channels that are known to be required for 
heart function.
Cdc42 has a conserved, essential role in regulating cell 
cycle, directed migration, epithelial polarity, and cell fate speci-
fication (Brown et al., 2006; Heasman and Ridley, 2008); and in 
adult mouse cardiomyocytes Cdc42 is involved in growth and 
prevention of hypertrophy (Maillet et al., 2009). Here, we find 
that the genetic interaction between Cdc42 and Nkx2-5 is con-
served in the mouse, and that Cdc42 and Nkx2-5 synergize to 
regulate heart function and physiology, which is likely mediated 
by miR-1. These data suggest that Cdc42 plays a conserved role 
in establishing and maintaining normal heart function down-
stream of, and potentially in concert with, the cardiac deter-
minant tinman/Nkx2-5.1183 Cdc42-Tin/Nkx2-5 in the heart • Qian et al.
suggesting that Cdc42 is essential for maintaining normal heart 
function. These Cdc42
N17 mutant hearts, when assessed for their 
beating pattern, also show increased incidence of arrhythmias 
and an overall lower heart rate, due to lengthening of diastolic 
intervals, compared with controls (Fig. 2, A–F). Using the mean 
standard deviation of heart period as an indicator of heart rhythm 
disturbance (“arrhythmia index”; Ocorr et al., 2007; Fink et al., 
2009), we found a dramatic increase in arrhythmias in Cdc42
N17 
hearts (Fig. 2 F). These effects are more dramatic than in Cdc42 
heterozygotes and together strongly support a crucial require-
ment for Cdc42 in regulating adult heart function.
The defective Cdc42
N17 adult hearts also showed abnor-
malities in the cellular architecture of the cardiomyocytes, as 
manifest by severely misaligned myofibrils and irregularities in 
the repeated Z-line pattern (Fig. 2, G–I). These structural abnor-
malities in Cdc42 mutant hearts are consistent with Cdc42’s role 
in actin filament assembly, also observed in Drosophila nurse 
For this purpose, we expressed a dominant-negative form of 
Cdc42  (UAS-Cdc42
N17;  Luo  et  al.,  1994)  specifically  in  the 
adult heart using tinC4Gal4 (a UAS-Gal4 system that drives 
gene expression only in myocardial cells; Qian et al., 2005a), or 
in all mesoderm using 24BGal4 (drives gene expression pan-
mesodermally; Brand and Perrimon, 1993). The UAS-GAL4 
system has two parts: the GAL4 gene that encodes the yeast 
transcriptional activator protein Gal4, and the upstream activa-
tion sequence (UAS), which is a short section of the promoter 
region to which Gal4 specifically binds to activate gene tran-
scription (Brand and Perrimon, 1993). By using the TARGET 
system (Gal4/Gal80, see Materials and methods; McGuire et al., 
2004) in combination with UASCdc42
N17, we specifically inter-
fered with Cdc42 function in the adult heart without disturbing 
its function in the embryo. Interference with Cdc42 function 
specifically in the heart within the first week of adult life causes 
a dramatic increase in pacing-induced heart failure (Fig. 1 C), 
Figure 1.  Genetic screen identifying Cdc42. (A) Candidate deficiency lines interacting with tin
346 (susceptibility to pacing-induced heart arrest or fibrilla-
tion). (B) Genetic interaction between tinman, Cdc42, and deficiency 7721. Cdc42
+/;tin
+/ flies show dramatic increase in pacing-induced heart arrest 
or fibrillation rate compared with Cdc42
+/ or tin
+/ (Chi square analysis: *, P < 0.01). (C) TARGET-mediated overexpression (see Materials and methods) 
of dominant-negative Cdc42 (Cdc42
N17) in the adult heart results in elevated heart dysfunction (*, P < 0.01). Each bar in B and C represents a single 
experiment. n, number of flies tested.JCB • VOLUME 193 • NUMBER 7 • 2011   1184
Figure 2.  Cdc42 is required for adult heart function in flies. (A–C) Cardiac M-mode traces prepared from high speed movies of semi-intact flies. (A) M-mode 
from control flies shows a regular beating pattern. (B and C) Arrhythmic heart beats are evident in flies overexpressing Cdc42
N17 using tinC4-Gal4 (G) or 
24BGal4 (H). (A–C) Heart period histograms. (D–F) Statistical analysis of Cdc42
N17 mutant heart contractions (relative quantification [RQ] compared with 
control). Disruption of Cdc42 in the adult heart results in longer diastolic but not systolic intervals (D and E) and in increased incidence of arrhythmias (F). Error 
bars represent SEM. (G–I) -Actinin labeling of the adult heart (one segment). Cdc42
N17 adult heart or Cdc42, tinman double heterozygotes show disruption of 
cardiomyocyte myofibrillar alignment. Bars, 50 µm. (J and K) Quantification of abnormalities in Cdc42
N17 and Cdc42
+/;tin
+/ hearts. Severity is determined 
by the average number of segments with significant abnormal myofiber structure. n, number of flies tested. Unpaired Student’s t test: *, P < 0.05.1185 Cdc42-Tin/Nkx2-5 in the heart • Qian et al.
these  two  potential  downstream  effectors,  we  generated 
Cdc42+/;dSUR+/ and Cdc42+/;slo+/ flies. These trans-
heterozygotes showed a defective cardiac structure as deter-
mined by -Actinin staining (Fig. S2, C–H). These hearts do 
not show dramatically altered heart beat intervals (Fig. S2,   
I and J), but they do beat more arrhythmically than single hetero-
zygous controls, as indicated by an increased arrhythmia index 
(Fig. 3 I). This suggests that Cdc42 indeed interacts with dSUR 
and slo to ensure normal heart structure and function. This in-
teraction phenotype also suggests the possibility that malfunc-
tioning ion channels may contribute to the structural remodeling 
(see Discussion). Interestingly, expression of dSUR is also down-
regulated in the heart with age, and old fly hearts exhibit func-
tional  abnormalities,  including  an  increased  incidence  of 
arrhythmias and pacing-induced heart failure (Akasaka et al., 
2006; Ocorr et al., 2007), similar to what we observed in the 
(young) Cdc42+/;tin+/ adult flies.
To further explore how Cdc42 interacts with tinman in 
regulating dSUR expression, we took advantage of a previously 
published enhancer element of dSUR (Akasaka et al., 2006) and 
performed luciferase assays in Drosophila S2 cells transfected 
with  Cdc42  and/or  tinman  expression  constructs.  Consistent 
with the previous results, the dSUR enhancer element is responsive 
to cotransfection with a tinman expression construct (Fig. 3 G). 
Importantly, luciferase activity is dramatically enhanced by ad-
dition of a Cdc42 construct whereas transfection of Cdc42 by 
itself did not exert any effect on this enhancer (Fig. 3 G). Mutat-
ing the Tinman binding site in this enhancer abolished the re-
sponsiveness (Fig. 3 G). Conversely, addition of Cdc42 did not 
enhance the transcriptional activity of another transcription fac-
tor, the GATA factor Pannier, which in turn synergizes dramati-
cally with Tinman in this assay (Fig. 3 G), as well as in vivo 
(Akasaka et al., 2006). These data suggest that Cdc42 may co-
operate with Tinman (but not with Pannier) to activate the dSUR 
enhancer directly rather than by acting indirectly through sepa-
rate pathways in the regulation of dSUR expression. This is con-
sistent with the idea that the changes in expression of these ion 
channel genes may not be secondary to the sarcomeric defects 
in Cdc42+/;tin+/ hearts. However, indirect mechanisms of 
Cdc42 interaction with Tinman’s transcriptional activity cannot 
be ruled out, as it is also possible that the myofibril alignment 
defects are secondary to the contractility defects, but all these 
considerations have to await future analysis. Based on the ge-
netic interaction of Cdc42 with tinman presented here, it is sug-
gested that Rho GTPases may represent a novel class of cardiac 
disease genes and/or act as polygenic interactors with known 
heart disease genes, such as tinman/Nkx2-5.
Cdc42 interacts with Nkx2-5 in 
modulating adult mouse heart function
Because Cdc42 and tinman are conserved in vertebrates, we 
tested whether the interaction between them is also conserved 
in mice. We first generated compound Mm Cdc42
del/+;Nkx2-5
del/+ 
mice, which are viable at normal Mendelian ratios (unpublished 
data), and compared them to single-heterozygous littermates. 
We used high-resolution echocardiography to monitor structural 
and functional aspects of the postnatal mouse heart (Fig. 4, A–E). 
cells, neurons, and epithelial cells (Genova et al., 2000; Jacinto 
et al., 2000; Jhaveri and Rodrigues, 2002). During Drosophila 
dorsal closure, Cdc42 activates the serine/threonine protein kinase 
Pak to regulate dynamic actin structure and epithelial plasticity 
(Harden et al., 1996; Bahri et al., 2010). Therefore, we reasoned 
that Cdc42 may act through the Pak pathway to regulate actin   
filament assembly and thus myofibrillar structure in the fly heart. 
To test this hypothesis, we generated Cdc42, Pak transheterozy-
gotes and examined their cardiac structure and function (Fig. S1). 
Indeed, the majority of these transheterozygous hearts exhibited 
heart tube abnormalities where the myofibrils were misaligned 
or had gaps between the fibrils, whereas the hearts from single 
heterozygotes appear wild type (Fig. S1, A–C). Furthermore, func-
tional analyses revealed that Cdc42, Pak double heterozygotes   
also exhibited other contractile abnormalities, which are likely 
due to the observed defects in myofibrillar organization. In con-
trast, the heart beat intervals and overall rhythmicity are not   
affected (Fig. S1, D–F), compared with Cdc42’s interaction with 
tinman (Fig. 2, A–F). These data are consistent with a Cdc42  
interaction with Pak in regulating cardiac actin alignment and 
thus the myofibrillar organization of the heart, but perhaps less so 
in regulating the heart rate and rhythm.
Cdc42–tinman interaction contributes to 
adult heart structure and function
To further explore the Cdc42–tinman interaction, we examined 
the contractility and beating patterns in double-heterozygous 
hearts.  Compared  with  the  single  heterozygotes,  both  tin
346/
Cdc42
3 and tin
346/Df(Cdc42) flies exhibit an irregular beating pat-
tern and a tendency toward longer diastolic intervals (Fig. 3, A–C), 
similar to Cdc42
N17 hearts (Fig. 2, A–F). The elevated arrhythmias 
are also illustrated in the broadening of the heart period distri-
bution in the double heterozygotes (Fig. 3, A and B). Thus, 
combined partial loss of Cdc42 and tinman function synergisti-
cally compromises heart function. In addition, Cdc42 also shows 
a synergistic interaction with tinman in establishing a regular 
myofibrillar structure of the adult heart (Fig. 2, I and K). In 
contrast,  a  transheterozygous  combination  of  Cdc42  with 
Df(2L)Exel6012, a deficiency covering the nmr/Tbx20 locus 
that also interacts with tinman (Qian et al., 2008b), fails to ex-
hibit such an interaction (Fig. S1, G–L). Thus, Cdc42 seems to 
engage in a specific genetic interaction with tinman to regulate 
adult heart function in the adult fly.
To determine how Cdc42 and tinman interact to maintain 
heart function, we examined the gene expression levels of a cadre 
of cardiac-specific potential targets or effectors of the Cdc42–
tinman interaction by quantitative RT-PCR (qPCR; see Materi-
als and methods for complete list). In particular, we focused on 
ion channel genes that have previously been shown to regulate 
heart function in the adult fly (Bodmer, 2005; Akasaka et al., 
2006; Ocorr et al., 2007; Qian et al., 2008a). Of these candi-
dates, the two potassium channels dSUR and slowpoke were 
most severely down-regulated (Fig. 3, D and E; see Fig. S2, A 
and B, for examples of genes showing no changes), and they 
have previously been shown to be required for normal car-
diac performance (Johnson et al., 1998; Akasaka et al., 2006).   
To  determine  whether  Cdc42  genetically  interacted  with JCB • VOLUME 193 • NUMBER 7 • 2011   1186
Figure 3.  Cdc42 and tinman interact to maintain normal cardiac contraction. (A and B) Representative M-mode traces showing arrhythmic heart contrac-
tions in Df(Cdc42)/+;tin
346/+ (B), compared with single heterozygotes Df(Cdc42)/+ (A). (A–B) Heart period histograms. (C) Statistical analysis of heart 
contraction in controls (w, tin
346/+, Cdc42
3/+, Df(Cdc42)/+) and Cdc42
3/+;tin
346/+ and Df(Cdc42)/+;tin
346/+ flies, shown as relative quantification 
(RQ). Error bars represent SEM; *, P < 0.05 (one-way ANOVA). (D and E) RQ of dSUR (A) and slowpoke (B) mRNA in 1-wk-old adult hearts (normalized to 
rp49, ribosomal protein 49) relative to control (w). Double heterozygotes Df(Cdc42)/+;tin
346/+, Df(Cdc42)/+;tin
EC40/+, and Cdc42
3/+;tin
346/+ showed 
lower expression than tinman or Cdc42 heterozygotes, or w controls. (F) Functional analyses of Cdc42,dSUR and Cdc42,slo double heterozygotes showed 1187 Cdc42-Tin/Nkx2-5 in the heart • Qian et al.
as in the fly. This could be due to compensatory or redundant 
mechanisms that may be more prevalent in mammals. Neverthe-
less,  our  data  show  that  Mm  Cdc42  interacts  strongly  with 
Nkx2-5 in the mouse heart and that this genetic interaction is es-
sential for proper cardiac contraction, electrical conduction, 
and rhythmicity.
Screening for CDC42 gene variants in 
human cohorts with heart disease
The strong evidence in fly and mouse that implicates Cdc42 as 
an important determinant of normal heart function points to 
CDC42 as a candidate gene for human heart disease. Mutations 
in the human homologue of tinman, NKX2-5, or other partici-
pants in the cardiogenic transcriptional network, TBX5, TBX20, 
and GATA4, have been associated with a variety of congenital 
and  adult-onset  heart  disease.  In  humans,  the  CDC42  locus 
maps to chromosome 1p36. Monosomy 1p36 is the most com-
mon terminal deletion syndrome and results in mental retarda-
tion and multiple congenital anomalies, including atrial septal 
defects (ASD), ventricular septal defects (VSD), patent ductus 
arteriosus (PDA), and dilated cardiomyopathy (DCM). Loss of 
CDC42 could possibly account for the cardiac defects of this 
syndrome, as well as for cases in which these defects occur in 
isolation. We performed mutation screening of the CDC42 gene 
in two heart disease patient populations from Houston (J. Towbin) 
and Sydney (D. Fatkin).
In the Houston study, 331 subjects with heart disease, in-
cluding 96 probands with dilated cardiomyopathy (DCM), 48 
with hypertrophic cardiomyopathy (HCM), 91 with left ven-
tricular noncompaction (LVNC), and 96 with congenital heart 
disease (CHD), as well as over 400 controls (over 800 chro-
mosomes), were examined for potential variants in the human 
CDC42 gene (GenBank/EMBL/DDBJ accession no. NM_001791; 
Table I). Seven nonsynonymous and seven synonymous vari-
ants and four intronic variants were identified. Six out of the 
seven nonsynonymous variants were polymorphic and identi-
fied in subjects and controls. A single rare nonsynonymous vari-
ant, c.539A>G, which is predicted to result in an amino acid 
change of T125A, was not detected in over 300 Caucasian and 
over 100 Hispanic controls (Table I). This variant was found in 
a sporadic CHD patient with an atrial septal defect (ASD) and a 
patent ductus arteriosus (PDA). The parents did not participate 
in the study. In the Sydney study, over 300 heart disease patients 
(AF, CHD, LVNC) and 100 controls were examined (Table II), 
with no apparent disease-causing mutations identified. Some X 
synonymous variants were identified and no nonsynonymous 
variants were found.
These data indicate that despite the clear biological signif-
icance of Cdc42 in the heart, coding sequence variants in the 
CDC42 gene are not a common cause of CHD or adult heart 
disease. A possible reason is that this small GTPase is extremely 
Mm  Cdc42
+/+;Nkx2-5
+/+,  Mm  Cdc42
+/+;Nkx2-5
del/+,  Mm 
Cdc42
del/+;Nkx2-5
+/+, and Mm Cdc42
del/+;Nkx2-5
del/+ adult mice 
were subjected to serial imaging at 4–12 wk after birth. At 4 wk 
of age, cardiac function in single heterozygotes (MmCdc42
del/+ 
or Nkx2-5
del/+) was not significantly different from wild-type lit-
termates, whereas double heterozygotes showed declining heart 
function as indicated by decreased fraction of blood ejected 
from the left ventricle with each contraction (ejection fraction, 
EF), the fractional shortening of the ventricular chamber (frac-
tional shortening, FS), volume of blood ejected with each heart 
beat (stroke volume, SV), and cardiac output (CO; see Fig. 4, 
A–D for quantification and Fig. 4 E for representative M-modes 
of the four genotypes). As the mice aged, single heterozygotes 
progressively  exhibited  weakened  pumping  ability,  whereas 
double heterozygotes always performed worse than their single-
heterozygous littermates (Fig. 4, A–D). Collectively, these re-
sults demonstrate that cardiac output, as assessed by multiple 
imaging parameters, is perturbed in Cdc42 heterozygous mice, 
and as expected in Nkx2-5 heterozygotes. Compellingly, these 
defects are markedly worse when the two alleles are combined 
in trans, suggesting that Cdc42 and Nkx2-5 synergistically reg-
ulate cardiac output and function in the mouse adult heart.
Mouse models of Nkx2-5 deficiency revealed a critical 
role for Nkx2-5 in establishing and maintaining proper cardiac 
conduction system function (Pashmforoush et al., 2004; Briggs 
et al., 2008; Takeda et al., 2009), and human mutations in Nkx2-5 
cause conduction-system dysfunction (Schott et al., 1998). Given 
the interaction between tinman and Cdc42 that we identified   
in the fly, we hypothesized that Nkx2-5 also interacts with 
Cdc42 in regulating the electrical activity of adult mouse heart. 
Therefore, we performed surface electrocardiography (ECG) 
and found that the average heart rate of single and double hetero-
zygotes is not significantly different from that of wild-type 
mice, nor is there any difference in the delay between atrial and 
ventricular depolarization as indicated by the PR interval (Fig. 4 F). 
However, combined reduction of Cdc42 and Nkx2-5 resulted in 
prolonged atrial depolarization manifested by increased P dura-
tion (Fig. 4 F). The QRS complex, the portion of an ECG that 
corresponds to the depolarization of the right and left ventricles, 
was also significantly prolonged in double heterozygotes and 
was associated with prolongation of the QT and QTc intervals 
(Fig. 4 F). We also noticed that the double heterozygotes showed 
signs of right bundle branch block based upon S wave depres-
sion and the delays, as calculated in Fig. 4 F, which was not ob-
served in single heterozygotes or wild-type controls. We then 
examined cardiac structure and fibrosis of these adult mice by 
performing  the  standard  hematoxylin  and  eosin  (H&E)  and 
Masson Trichrome stainings, but did not observe any consistent 
differences among different genotypes (unpublished data and 
Fig. S3). Thus, compound heterozygosity for Nkx2-5 and Cdc42 
does not alter cardiac morphology in the mouse as significantly 
a significant increase in the arrhythmia index. (G) Luciferase assay using the dSUR T3 enhancer (Akasaka et al., 2006). Note the increased relative lu-
ciferase activity (RLA) by transfection of Tin was further enhanced by cotransfection with Cdc42 or Pnr, but not when Pnr and Cdc42 were cotransfected. 
Mutation of the Tin site abolished the responsiveness. Experiments were repeated three times. Error bars represent SEM. Unpaired Student’s t test: *, P < 
0.05; **, P < 0.01.
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Cdc42 is a direct target of miR-1 that is 
negatively regulated by Nkx2-5
Examination of the upstream regulatory region of mouse miR-1 
revealed the presence of four Nkx2-5 consensus binding sites 
(Fig. 5 B). This made us wonder whether Cdc42 is regulated by 
miR-1, which would provide a possible mechanism for the ge-
netic interaction between Tinman/Nkx2-5 and Cdc42. Indeed, 
conserved, which does not allow for any sequence variation re-
sulting in an amino acid change to be tolerated, because most 
may result in lethality. Future mutation screening in intronic 
and regulatory regions of this gene, resulting in only partial loss 
of function, and studies in larger patient cohorts will likely pro-
vide further insights into the potential role of CDC42 as a new 
human heart disease gene.
Figure 4.  Compound haploinsufficiency of mouse Cdc42 (MmCdc42) and Nkx2-5 resulted in defective cardiac contraction and electrophysiological   
function. (A–D) Histograms showing echocardiographic parameters of MmCdc42
+/+;Nkx2-5
+/+, MmCdc42
+/+;Nkx2-5
del/+, MmCdc42
del/+;Nkx2-5
+/+, and 
MmCdc42
del/+;Nkx2-5
del/+ adult mice at 4, 8, and 12 wk. Combined reduction of MmCdc42 and Nkx2-5 worsened heart function shown as (A) lower 
fraction shortening (FS), (B) ejection fraction (EF), (C) stroke volume (SV), and (D) cardiac output (CO) at all time points. Unpaired Student’s t test (relative to 
wild type): *, P < 0.05; **, P < 0.01. (E) Representative M-mode echocardiograms illustrate decrease in contractility of MmCdc42
del/+;Nkx2-5
del/+ hearts 
(right panel, larger systole) compared with controls. (F) Table with electrocardiographic parameters of MmCdc42 and Nkx2-5 combinations in adult mice 
(± SEM). One-way ANOVA: *, P < 0.05; **, P < 0.01.1189 Cdc42-Tin/Nkx2-5 in the heart • Qian et al.
cotransfected with Nkx2-5 into HL-1 cells (Fig. 5 B). Mutations 
of the Nkx2.5 binding sites in the miR-1 enhancer abolished 
Nkx2-5 responsiveness (Fig. 5 B), suggesting that Nkx2-5 re-
presses miR-1 by directly binding to this enhancer.
Next, we tested whether miR-1 directly regulates Cdc42 
by transfecting HL-1 cells with miR-1 mimics (chemically syn-
thesized double-stranded oligonucleotides that mimic the func-
tion of endogenous mature miR-1) and miR-1 inhibitors (modified 
antisense oligoribonucleotides that inhibit miR-1 function). Over-
expression of miR-1 resulted in decreased endogenous Cdc42 
expression, whereas inhibition of miR-1 caused an increased 
expression of Cdc42 (Fig. 5 D), which is consistent with the pres-
ence of a conserved miR-1 binding site in the Cdc42 3-UTR 
(Fig. 5 G). To test whether miR-1 is capable of directly repress-
ing Cdc42 via this site, the Cdc42 3-UTR was inserted into the 
3-UTR of a luciferase reporter, downstream of the coding region. 
we identified a miR-1 consensus target site in the 3-UTR of 
Cdc42 (Fig. 5 G, see below).
To determine whether Nkx2-5 is capable of regulating 
miR-1 transcription we transfected an Nkx2-5 expression con-
struct into HL-1 cells, a line derived from atrial cardiomyocytes 
(Claycomb et al., 1998). We found a decrease in miR-1 levels 
detected by qPCR (Fig. 5 A). Similar results were obtained 
when we transfected Nkx2-5 into primary cardiomyocytes that 
were directly isolated from neonatal hearts (not depicted). This 
suggests that Nkx2-5 negatively regulates miR-1 in cardiomyo-
cytes. Furthermore, we identified four conserved Nkx2-5 bind-
ing sites in the 2.6-kb minimal enhancer region of miR-1 (Fig. 5 B). 
To test whether Nkx2-5 represses miR-1 by binding to these 
sites, the miR-1 enhancer was cloned upstream of the coding 
region of a luciferase reporter. A decrease in luciferase activ-
ity was observed when the constitutively active reporter was 
Table I.  Nonsynonymous or synonymous variants identified in CDC42 (NM_001791) in probands either with DCM, HCM, LVNC, or congenital 
heart diseases (Houston study)
Location Nucleotide 
change
Amino acid  
change
Type of  
variant
Patient group Frequency
DCM  
(n = 96)
HCM  
(n = 48)
CHD  
(n = 96)
LVNC  
(n = 91)
Amplicon1  
(Exon 1)
c.188G>T V8F NP 6 0 0 0 6/331 
(1.8%)
c.242A>C N26N S 1 0 0 0 1/331 
(0.3%)
c.256G>A S30S S 2 0 1 0 3/331 
(0.9%)
c.257G>C E31Q NP 46 11 52 29 138/331 
(41.7%)
c.271+6 T>G Intron 3 splice ds NP 2 5 0 0 7/331 
(2.1%)
Amplicon2 
(Exon2)
c.272-9 insT Intron3 splice as NP 4 0 0 0 4/331 
(1.2%)
c.272-7 T>C Intron3 splice as NP 5 2 0 8 15/331 
(4.5%)
c.272-2 T>C Intron3 splice as NP 6 0 4 3 13/331 
(3.9%)
c.289 A>C A41A S 4 0 2 1 7/331 
(2.1%)
c.295 A>C T43T S 5 0 0 0 5/331 
(1.5%)
c.317 T>C Y51H NP 1 22 14 10 47/331 
(14.2%)
Amplicon4  
(Exon 4)
c.502T>A L112L S 0 0 0 2 2/331 
(0.6%)
c.513A>C Q116P NP 5 0 0 1 6/331 
(1.8%)
c.523 C>T L119L S 7 0 1 2 10/331 
(3.0%)
c.525 G>A R120K NP 2 0 49 0 51/331 
(15.4%)
c.628 T>C Y154Y S 5 1 2 0 8/331 
(2.4%)  
(rs16826536)
c.539 A>G T125A Rare variant 0 0 1 0 1/331 
(0.3%)
Amplicon5 
(Exon5)
c.730 T>G C188W NP 3 0 10 12 25/331 
(7.5%)
DCM, dilated cardiac myopathy; HCM, hypertrophic cardiac myopathy; LVNC, left ventricular noncompaction; CHD, congenital heart disease; S, synonymous 
change; NP, nonsynonymous polymorphism.JCB • VOLUME 193 • NUMBER 7 • 2011   1190
may not always be conserved (Hyun et al., 2009; unpublished 
data), even though the pathway overall is likely conserved, 
as in this case and in a recent report (King et al., 2011). Thus, 
it remains to be determined how microRNAs regulate down-
stream effectors (such as Cdc42; Fig. 6 E), directly by cryptic 
sites or via an unknown possibly indirect mechanism. However, 
we did find two consensus binding sites for Tinman within the 
enhancer of fly miR-1, and luciferase assays in S2 cells revealed 
that these two sites are responsible for the regulation of fly 
miR-1 by Tinman (Fig. S5). Taken together, these data sug-
gest a functionally conserved regulatory pathway involving   
tinman–miR-1–Cdc42 in establishing cardiac functionality, al-
though some aspects of the molecular mechanisms involved 
may be different between flies and vertebrates, which could also 
explain the different severity in phenotypes between flies and 
mice in our study.
Discussion
Drosophila has been successfully used to study regulatory ge-
netic networks of inductive signals and transcription factors that 
determine cardiac specification and morphogenesis, but the   
genetic control of cardiac physiology is only beginning to be   
investigated. Using a cardiac performance-based genetic screen, 
we discovered a novel genetic interaction between Cdc42 and 
the NK homeobox gene tinman in regulating cardiac function in 
the fly. We have identified a heretofore-unknown requirement 
for the Rho GTPase Cdc42 in regulating the establishment of 
cardiac function in the adult fly. Significantly, this interaction is 
conserved in mice, where combined reduction of Cdc42 and 
Nkx2-5 caused defects in heart contraction, rhythm, and electro-
physiological function. Based on the discovery of the interac-
tion between this Rho GTPase with a cardiogenic transcription 
factor in maintaining proper cardiac function, it is conceivable 
that other genetic interactors and potential polygenic contribu-
tors to heart disease traits can be identified using the fly as a 
screening platform.
Cdc42 is a well-characterized GTPase, and has been widely 
studied in different organs and tissues, ranging from worms to 
humans. Because Cdc42 was shown to be involved in regulation 
of the actin/myosin cytoskeleton in the cells of various organ-
isms, we reasoned that Cdc42 might also control cardiac cell 
morphogenesis. In Drosophila and mouse we found that complete 
Transfection  of  the  Cdc42  3-UTR  luciferase  reporter  with 
miR-1 mimic into HL-1 cells results in a decrease in luciferase 
activity, whereas cotransfection with miR-1 inhibitor increases 
luciferase activity (Fig. 5 G). A gradient of miR-1 was used to con-
firm the luciferase activity was dose responsive (Fig. S4 A). Muta-
tions of the miR-1 binding site in the Cdc42 3-UTR abolished 
miR-1 responsiveness (Fig. 5 G), suggesting that miR-1 represses 
Cdc42 by physically binding to its 3-UTR.
We extracted RNA and protein from transgenic mice in 
which miR-1 was overexpressed in the adult heart via the   
-MHC promoter (-MHC–miR-1; unpublished mice from the 
Srivastava laboratory) and examined Cdc42 mRNA and protein 
levels. Consistently, miR-1 transgenic hearts showed signifi-
cantly reduced Cdc42 mRNA and protein levels (Fig. 5, E and F), 
suggesting a repressive relationship between miR-1 and Cdc42 
in vivo. We did not observe increased Cdc42 expression in miR-
1-2 knockout hearts, which might be due to the incomplete de-
pletion of miR-1 expression because of the intact miR-1-1 locus 
(Zhao et al., 2007; unpublished data). Furthermore, we deter-
mined  miR-1  levels  in  Nkx2.5  knockout  embryos  (E9.5)  by 
qPCR and found an increase in miR-1 levels compared with litter-
mate controls (Fig. 5 C). These data provide further evidence 
that the genetic interaction between Nkx2-5 and Cdc42 is medi-
ated by miR-1.
We then wondered whether the genetic interaction be-
tween tinman and Cdc42 in Drosophila is also governed by a 
double-inhibitory mechanism involving the fly homologue of 
miR-1. We found that cardiac-specific overexpression of miR-1 
causes an increase in arrhythmias (Fig. 6, A–D), comparable to 
cardiac expression of dominant-negative Cdc42
N17 (Fig. 2). In addi-
tion, fly hearts with excessive cardiac miR-1 expression exhibit 
reduced levels of Cdc42 and slo mRNA in the heart (Fig. 6 E),   
suggesting that miR-1’s influence on heart function includes   
inhibition of Cdc42 and one or more potassium channels. In con-
trast to the mouse, however, we did not identify any miR-1 
binding sites in the 3-UTR of fly Cdc42. To test whether   
fly Cdc42 regulation by miR-1 is through binding to “seedless”   
3’-UTR sequences that lack predicted microRNA recognition 
elements (Bamshad et al., 1997), we cloned fly Cdc42 3-UTR 
into the 3-UTR of a luciferase reporter and performed luciferase 
assays in Drosophila S2 cells. However, we did not observe 
consistent and reproducible repression in the presence of miR-1 
(Fig. S4 B). Recent evidence suggests that microRNA target sites 
Table II.  Cdc42 variants identified in 328 individuals with adult and congenital heart disease (Sydney study)
Location Variant Amino acid 
change
Patient group Published SNP  
frequency
Reference
AF (n = 100) CHD (n = 200) LVNC (n = 28)
Intron 3 22G>T NA 3 (0.03%) 1 (0.005%) 0 NA Rs41300114
Intron 3 8insT NA 3 (0.03%) 8 (0.04%) 0 NA Novel
Intron 3 3T>C NA 0 0 1 (0.04%) 3/90 (0.03%) Rs17837976
Exon 5 180G>A G60G 0 1 (0.005%) 0
Exon 5 276C>T N92N 1 (0.01%) 0 0 1/90 (0.01%) Rs16826534
Exon 6 462T>C Y154Y 1 (0.01%) 0 0 4/85 (0.05%) Rs16826536
Exon 8 546G>A P182P 0 0 1 (0.04%) 1/85 (0.01%) Rs16826536
AF, atrial fibrillation; CHD, congenital heart disease; LVNC, left ventricular noncompaction; NA, not available; SNP, single nucleotide polymorphism.1191 Cdc42-Tin/Nkx2-5 in the heart • Qian et al.
Figure 5.  MmCdc42 is a direct target of miR-1 that is negatively regulated by Nkx2-5. (A) Relative levels (RQ) of miR-1 expression determined by qPCR in 
HL-1 cells electroporated with Nkx2-5 compared to control (GFP). (B) A 2.6-kb miR-1-1 enhancer luciferase construct containing four wild-type or mutated 
Nkx2-5 sites (Zhao et al., 2005) was cotransfected with Nkx2-5. (C) qPCR of miR-1 from Nkx2-5
del/del mouse embryos (E9.5) relative to wild-type litter-
mate controls. (D) qPCR of Cdc42 mRNA levels from HL-1 cells transfected with miR-1 mimic or miR-1 inhibitor. Experiments were done in three biological 
triplicates and technical quadruplicates. (E) qPCR of MmCdc42 mRNA from 4 miR-1 transgenic mouse hearts (MHC-miR-1) compared with four littermate 
controls. (F) Western blot of MmCdc42 protein from MHC-miR-1 transgenic and control mice. (G) RLA from cells cotransfected with a luciferase reporter—
containing wild-type or mutated miR-1 target site in the Cdc42 3UTR—and a miR-1 mimic or inhibitor. Experiments (each condition) were repeated three 
times with technical quadruplicates. Unpaired Student’s t test: *, P < 0.05; **, P < 0.01.JCB • VOLUME 193 • NUMBER 7 • 2011   1192
with a previous report in a tissue culture model for cardiac hyper-
trophy showing that sarcomere units are misassembled in cul-
tured rat cardiomyocytes when Cdc42 expression is disrupted 
(Nagai et al., 2003; Brown et al., 2006). In addition, Cdc42 in 
Drosophila interacts with a known downstream effector of Cdc42, 
Pak, which participates in actin filament assembly and dynamics 
(Harden et al., 1996; Bahri et al., 2010), thus consistent with a 
possible role for Cdc42 in myofibrillar organization.
Similar  to  our  Cdc42;Nkx2-5  compound  heterozygote 
analysis, it has been shown that mice transheterozygous for 
loss-of-function alleles of Nkx2-5 and Tbx5 also exhibit a syner-
gistic interaction, in particular with respect to the development 
of the cardiac conduction system (Moskowitz et al., 2007). It is 
therefore likely that other cardiac transcription factors in com-
bination with new genes will reveal similar patterns of interac-
tions in flies and mammals. Although different model organisms 
have been used to study cardiac disease, the ability to investi-
gate polygenic traits underlying these diseases in a systematic 
loss of Cdc42 in the heart leads to defects in cardiac morpho-
genesis (unpublished data). In the adult heart, Cdc42 was previ-
ously shown to be associated with cardiac myocyte hypertrophy 
(Clerk and Sugden, 2000; Pandur et al., 2002; Sellin et al., 2006). 
Recent work shows that Cdc42 plays a protective role against   
hypertrophy, as conditional deletion of Cdc42 in the adult heart led 
to greater cardiac hypertrophy and increased incidence of heart 
failure (Maillet et al., 2009). Interestingly, our findings show that 
interference with Cdc42 function in the adult fly heart via expres-
sion of a dominant-negative form of Cdc42 is sufficient to induce 
functional and morphological defects, suggesting that, in addi-
tion to interacting with tinman, Cdc42 itself is essential for main-
taining normal adult heart structure and function. The specific 
differences between the fly and the mouse phenotypes in these 
studies may be attributed to differences in assays as well as to 
evolutionary changes of Cdc42 function from insects to verte-
brates. However, the fact that Cdc42 adult-specific mutant fly 
hearts are defective in Z-line/myofibril assembly is consistent 
Figure 6.  Overexpression of miR-1 causes arrhythmias in the adult fly heart. (A) M-mode traces illustrate arrhythmic heart contractions with cardiac   
miR-1 overexpression (tinC4Gal4/UASmiR-1). (B–D) Statistical analysis of heart contraction in miR-1–overexpressing adult hearts. (E) Cardiac qPCR of fly 
Cdc42 (DmCdc42) and potassium channels slowpoke (slo) with tinC4Gal4/UASmiR-1. Heart-specific overexpression of miR-1 resulted in reduced cardiac 
expression of Cdc42 and slo. *, P < 0.05.1193 Cdc42-Tin/Nkx2-5 in the heart • Qian et al.
In conclusion, we have used the power of Drosophila ge-
netics to uncover a new, conserved genetic pathway, linking genes 
with critical heart functions, tinman/Nkx2-5, miR-1, and Cdc42, 
to a novel network regulating adult heart physiology and perfor-
mance. With the fly as a screening platform, it is thus possible to 
identify new polygenic contributors that ensure normal cardiac 
function relevant to human heart disease.
Materials and methods
Drosophila stocks
The following mutant stocks were used: Cdc42
3/FM6 (Boutros et al., 1998); 
tin
346/TM3-ftz-lacZ (Azpiazu and Frasch, 1993); tin
EC40/TM3, Df(3R)tinGC14 
(Bodmer, 1993); Pak
6/TM3,Sb (Pehlivan et al., 1999); Df(2L)Exel9032/
Cyo (indicated as dSUR/+), Df(3R)BSC397/TM3,Sb (indicated as slo/+), 
Df(2L)Exel6012 (Qian et al., 2005b; Exelixis deficiency deleting both nmr1 
and nmr2, also indicated as Df(nmr)), and Df(1)Exel6253 (Exelixis deficiency 
deleting the whole genomic region of Cdc42, also indicated as Df(Cdc42)). 
Wild-type control flies are w
1118. Overexpression of transgenes was achieved 
using the UAS-Gal4 system (Brand and Perrimon, 1993). The following 
Gal4 and UAS lines were used: twi-Gal4 (twi>; Greig and Akam, 1993), 
24B-Gal4 (24B>; Brand and Perrimon, 1993), the double combination twi-
Gal4;24B-Gal4 (twi24B>; pan-mesodermal expression; Lockwood and 
Bodmer, 2002), tinC4-Gal4 (Lo and Frasch, 2001), and UAS-Cdc42
N17 (Luo   
et al., 1994). We used TARGET to temporally and spatially activate gene ex-
pression (McGuire et al., 2004). In brief, we raised flies (with Gal4, Gal80-
ts, and UAS constructs) at 18°C before eclosion; after eclosion we raised 
adult flies at 29°C for 1 wk and then performed heart function assays.
Mouse stocks
Mice harboring a loss-of-function allele for Nkx2-5 (Nkx2-5
del/+/Nkx2.5
tm1Siz) 
have been described previously (Tanaka et al., 1999). Mice harboring a 
floxed allele of Cdc42 (Cdc42
tm1Yizh) have also been described previously 
(Chen et al., 2006). Cdc42 males were bred to Mef2c-AHF-cre (Verzi et al., 
2005) females to enable germ line deletion of Cdc42 (Cdc42
del/+), and off-
spring that did not inherit the Cre allele were then mated to Nkx2.5 hetero-
zygous animals to generate compound heterozygous and single heterozygous 
offspring. For all functional studies detailed below, littermates of each indi-
cated genotype were analyzed.
Immunohistochemistry
For fly heart immunohistochemistry, antibody staining was performed as 
described previously (Han et al., 2002). In brief, after micro-dissection, fly 
hearts were fixed in 4% PFA overnight at 4°C. After blocking in 10% BSA 
(Sigma-Aldrich)/PBS for 1 h, fly hearts were incubated in primary antibodies 
for 1 h, washed three times (15 min each) with PBT (PBS + 0.5% Triton), and 
then incubated in secondary antibodies for 1 h. After washing 3 × 15 min in 
PBT, fly hearts were mounted in VectaShield (Vector Laboratories). Cy3- or 
FITC-conjugated secondary antibodies (Jackson ImmunoResearch Laborato-
ries, Inc.) were used for fluorescent confocal microscopy. All the secondary 
antibodies were used at 1:200. Fly heart preparations were analyzed using 
a confocal microscope (model LSM510; Carl Zeiss). Mouse anti–-Actinin 
(Saide et al., 1989) was used in this study. For mouse heart immunohisto-
chemistry, after perfusion fix the heart was removed and fixed by immersion 
in 4% PFA in PBS (diluted from 20% PFA stock; Electron Microscopy Sciences) 
and routinely processed and paraffin embedded. 5-µm sections were stained 
with hematoxylin and eosin (H&E) and Masson Trichrome and analyzed for 
regular morphology and fibrosis. Images were acquired by Zeiss LSM soft-
ware (for confocal images) or Image-Pro Plus 5.1 (for regular IHC images). 
Adobe Photoshop was used for image processing; contrast and brightness 
were adjusted for better visualization.
Electrical pacing in flies
The electrical pacing was conducted as described previously (Wessells and 
Bodmer, 2004; Wessells et al., 2004). In brief, 50–100 flies were paced 
with a square wave stimulator at 40 V and 6 Hz for 30 s and scored for heart 
failure rate, defined as the percentage of flies that either exhibit cardiac arrest 
or continuous fibrillation immediately after pacing.
Image analysis and M-mode traces on semi-intact fly preparations
Procedures used were as described previously (Ocorr et al., 2007; Fink et al., 
2009). In brief, flies were anesthetized and the head, ventral thorax, and 
fashion in the adult is limited. Here, we provide evidence that 
rigorous screening for modifiers of heart disease can be achieved 
using Drosophila, leading to identification of similar polygenic 
trait interactions in mammals.
The genetic relationship between fly Cdc42 with the car-
diac determinant tinman in regulating adult heart contraction 
may occur, in part, via modulation of potassium channel gene 
expression, dSUR and slo, which have previously been shown to 
be critical regulators of heart function (Johnson et al., 1998; 
Akasaka et al., 2006). Indeed, Cdc42-dSUR or –slo transhetero-
zygotes show a strong interaction reflected in increased ar-
rhythmias. Interestingly, these transheterozygotes also exhibit 
disturbances in myofibrillar organization, suggesting these ion 
channel abnormalities somehow also produce sarcomeric de-
fects, perhaps via a secondary structural remodeling effect. 
Although there is increasing evidence of such remodeling pro-
cesses being affected by ion channel defects (unpublished data), 
the underlying mechanism is not yet understood.
A strong interaction was also observed between the mouse 
homologues of Cdc42 and Nkx2-5 in adult heart function. Most 
interestingly, double haploinsufficiency of Cdc42 and Nkx2-5 
led to elongated QRS intervals, which is typical of abnormal 
conduction along the atrio-ventricular bundle, bundle branches, 
and Purkinje fibers. The observed elongated QT intervals in 
compound  heterozygotes  are  also  characteristic  of  long-QT 
syndrome in humans. These findings suggest a possible contri-
bution of compound haploinsufficiency of Cdc42 and Nkx2-5 in 
human cardiac conduction diseases.
While attempting to elucidate the mechanistic link be-
tween Cdc42 and Nkx2-5, we found that miR-1 directly re-
presses Cdc42 and that miR-1 itself can be repressed by Nkx2.5 
expression. miR-1 is the first microRNA identified in the heart 
and plays a conserved role in cardiac morphogenesis, cell cycle, 
and conduction (Zhao et al., 2005, 2007). miR-1 null mutant 
mice  showed  cardiac  conduction  defects  including  widened 
QRS complex and prolonged QT intervals (Zhao et al., 2007), 
which is also affected in Cdc42;Nkx2-5 double-heterozygous 
mice. We speculate that loss or gain of miR-1 function causes 
an imbalance in gene expression in the heart, including that of 
Cdc42. Decreasing the copy number of the direct miR-1 target 
Cdc42,  and  that  of  a  direct  transcriptional  miR-1  repressor, 
Nkx2-5,  apparently  destroys  a  delicate  balance  in  the  adult 
heart, tipping it toward deregulated cardiac function. This does 
not rule out that other mechanisms are also involved in the ge-
netic interaction between Cdc42 and Nkx2-5. Because Cdc42 is 
a direct target of miR-1 and has a crucial function in modulating 
hypertrophic responses in the mouse, it will be interesting to 
test whether miR-1 and other microRNAs play a direct role in 
adult cardiac hypertrophy. Interestingly, Cdc42 was also found 
to be a target of miR-133, which is involved in cardiac hyper-
trophy (Carè et al., 2007). Thus, the RhoGTPase Cdc42 appears to 
be directly regulated by two major cardiac microRNAs that are 
involved in controlling cardiac function and hypertrophy. The 
synergistic transcriptional activation of the dSUR enhancer by 
Tinman and Cdc42 in vitro (Fig. 3 G) is consistent with the idea 
that Cdc42 can act in a coactivating mechanism with Tinman, 
but this remains to be further investigated.JCB • VOLUME 193 • NUMBER 7 • 2011   1194
Cell culture, transfection, and luciferase assay
HL-1 cells were maintained in Calycomb Medium supplemented with 100 µM 
norepinephrine,  10%  FBS,  and  4  mM  l-glutamine.  Cells  were  main-
tained at 37°C in a humidified atmosphere of 5% CO2/95% air. Lipo-
fectamine  2000  (Invitrogen)–mediated  transfection  was  performed 
according to Invitrogen’s protocol. miR-1 mimic and inhibitor were pur-
chased from Thermo Fisher Scientific. For each transfection in one well of 
a six-well plate, 40 pmol of mimic or inhibitor was used. For plasmid trans-
fection, 100 ng of plasmid was transfected in one well of a six-well plate 
using the Amaxa Nucleofection kit (Lonza) per the manufacturer’s protocol. 
Luciferase assays were performed as described previously (Zhao et al., 
2005) with the Dual-Luciferase Reporter Assay System (Promega). Cdc42 
3-UTR was cloned from mouse genomic DNA with the following primers: 
5-ACTAGTACGCATCTCCAGAGCCCTTTCTGC-3  and  5-AAGCTTTAG-
CCCTGACTGGTCCCCATGTTGG-3. Amplified DNA was cloned into 
pCRII vector and subsequently cloned into pMIR-REPORT vector (Invitro-
gen). Site-directed PCR-mediated mutagenesis was performed using the 
QuickChange II XL Site-Directed Mutagenesis kit (Agilent Technologies). 
Plasmids containing Tinman and Nkx2.5 have been described previously 
(Akasaka et al., 2006; Takeuchi and Bruneau, 2009). Tinman cDNA was 
finally inserted in pUAST vector; Nkx2-5 cDNA was finally inserted in 
pCDNA3.1 vector. Luciferase constructs containing miR-1 enhancer and 
dSUR enhancer were described previously (Zhao et al., 2005; Akasaka   
et al., 2006).
Western blots
Western blots were performed as described previously (Zhao et al., 2005). 
Rabbit  anti-Cdc42  (Cell  Signaling  Technology)  and  rabbit  anti-GAPDH 
(Santa Cruz Biotechnology, Inc.) were both used at a 1:1,000 dilution for 
Western blots. All Western blots were quantified using AlphaImager soft-
ware from Alpha Innovations.
Statistics
Mean, standard deviation, and standard error of the mean were calcu-
lated. Error bars are represented as standard error of the mean. Sample 
numbers were indicated in corresponding figures. Comparisons between 
groups were made by one-way ANOVA or unpaired two-tails assuming 
equal variance t test, as applicable. For fly pacing experiments, 
2 test 
was applied.
Human subjects and DNA sequence analysis
Houston study. The study population from Baylor College of Medicine in-
cluded 331 unrelated pediatric probands either sporadic or familial cases 
of heart disease including 96 individuals with dilated cardiomyopathy 
(DCM), 48 individuals with hypertrophic cardiomyopathy (HCM), 96 indi-
viduals with congenital heart disease (CHD), and 91 individuals with either 
isolated or nonisolated left ventricular noncompaction (LVNC; Table I). All 
patients were evaluated by physical examination, chest radiography, electro-
cardiography, echocardiography, cardiac magnetic resonance imaging 
(cMRI), and angiography. Left ventricular size and function was evaluated 
by M-mode and two-dimensional echocardiography, Doppler, and color 
Doppler analyses. Further details on heart function measures are as de-
scribed in Qian et al. (2008b). All subjects or their guardians provided 
written informed consent. Blood for EBV-transformed lymphoblastoid cell 
lines and DNA extraction was obtained, as regulated by the Baylor College 
of Medicine Institutional Review Board. DNA was extracted either directly 
from blood or from cultured cells using the Puregene DNA Isolation kit 
(Genetra Systems) according to the manufacturer’s protocol. Primers were 
designed in to the intron sequences flanking coding exons of CDC42 
(Genbank/EMBL/DDBJ  accession  no.  NM_001791).  Protein  encoding 
amplicons were amplified by polymerase chain reaction using genomic 
DNA, as described previously (Qian et al., 2008b). PCR products were 
purified and sequenced by automated sequencing using a DNA sequencer 
(ABI 3730; Applied Biosystems) and Big Dye terminator chemistry (version 
3.1) according to the manufacturer’s instructions. The only rare variant we 
found was T125A in a CHD patient. Over 300 Caucasian and >100 His-
panic controls were analyzed for all variants identified.
Sydney study. The population study in Australia was comprised of 
100 individuals with adult-onset familial atrial fibrillation (AF), 200 individ-
uals with CHD, comprised of ventricular septal defect (VSD), n = 113; 
atrial septal defect (ASD), n = 59; patent ductus arteriosis (PDA), n = 28, 
and 28 individuals with isolated or syndromic LVNC. Seven sequence vari-
ants were identified, including four synonymous amino acid substitutions 
and three intronic variants. Five of these variants have been reported previ-
ously and two were novel (Table II). Of note, the T125A variant from the 
ventral abdominal cuticle were removed. All internal organs except the heart 
were removed as well as any abdominal fat. Dissections were done under 
oxygenated saline (108 mM Na
+, 5 mM K
+, 2 mM Ca
2+, 8 mM MgCl2, 1 mM 
NaH2PO4, 4 mM NaHCO3, 10 mM sucrose, 5 mM trehalose, and 5 mM 
Hepes, pH 7.1). These semi-intact preparations (Ocorr et al., 2009; Vogler 
and Ocorr, 2009) were allowed to equilibrate with oxygenation for 10–20 
min before filming. These procedures were performed at room temperature. 
Image capture of heart contractions was performed using an EM-CCD digital 
camera (Hamamatsu Photonics) on a microscope (model DM LFSA; Leica)   
using direct immersion lenses. High-speed movies taken at rates of 100–200 
frames per second were acquired and contrast enhanced using Simple PCI 
imaging software (Compix, Inc.). Movie analysis and M-mode generation 
was performed using a MatLab-based image analysis program (Ocorr et al., 
2007, 2009; Fink et al., 2009; Vogler and Ocorr, 2009).
Mouse echocardiography
The mouse protocol was approved by institutional guidelines (UCSF). All 
analyses were performed in a blinded fashion for genotype and intervention. 
Mice were anesthetized with 2.4% isoflurane/97.6% oxygen and placed in 
a supine position on a heating pad (37°C). Echocardiography was per-
formed by a High-Resolution Micro-Imaging System (Vevo 770; VisualSonics) 
with a 15-MHz linear array ultrasound transducer. The left ventricle (LV) was 
assessed in both parasternal long-axis and short-axis views at a frame rate of 
120 Hz. End-systole or end-diastole was defined as the phase in which the 
smallest or largest area of LV, respectively, was obtained. Left ventricular end-
systolic diameter (LVESD) and left ventricular end-diastolic diameter (LVEDD) 
were measured from the LV M-mode tracing with a sweep speed of 50 mm/s 
at the papillary muscle level.
Mouse electrocardiography
For surface electrocardiography, mice were anesthetized with 1.75% isoflu-
rane at a core temperature of 37–38°C. Four needle electrodes (AD Instru-
ments) were placed subcutaneously in standard limb lead configurations. For 
each mouse, 10–20 s of continuous signals were sampled at 10 KHz in each 
lead configuration using a PowerLab4/30 interface (AD Instruments). Data 
analysis was performed offline using electronic calipers on averaged beats 
(Chart5Pro v5.4.2; AD Instruments). The QRS interval was measured from the 
onset of the Q-wave to the isoelectric point preceding the first, rapid repolar-
ization wave. The QT interval was measured from the onset of the Q-wave to 
the end of the second, slower repolarization wave. The measured QT interval 
was corrected for heart rate using the rodent correction formula, QTc = 
QT/(RR/100)0.5.
Quantitative real-time PCR (qPCR)
For fly qPCR, total RNA was extracted from 20 dissected hearts of 1-wk-old 
adult females by using TRIzol (Invitrogen). After lysis with TRIzol followed 
by phase separation, the aqueous phase was subjected to RNA extraction 
(Mini RNA Isolation kit; Zymo Research) with on-column DNaseI treatment 
(QIAGEN). After RNA extraction with RNase-free water, the first-strand 
cDNA  was  immediately  transcribed  with  SuperScript  III  (Invitrogen)  by   
using oligo(dT) primer, followed by the second-strand synthesis with DNA 
polymerase I, E. coli DNA ligase, and RNase H. Quantitative PCR was 
performed using the LightCycler FastStart DNA Master PLUS SYBR Green I 
kit (Roche). The primer sets were as follows: for rp49, 5-GACGCTTCAAG-
GGACAGTATCTG-3 and 5-AAACGCGGTTCTGCATGAG-3; for dSUR, 
5-CATCACCATTGCCCATCGTCT-3 and 5-CGCCCTTCTCCAGTAAACC-3;   
for slowpoke, 5-GCCAACAGATCAGGTATTCGT-3 and 5-GCGCTACA-
CAGTAACAATCA-3; for cdc42, 5-CTACACACTGGGCCTGTTC-3 and 
5-TTTGGCAATGGTGTGTAATC-3.  The  following  gene  expressions  did 
not show any consistent and/or significant difference among the geno-
types we tested: potassium channel genes: shaker, shaker-like, seizure,   
Inwardly rectifying potassium channel (Ir), and KCNQ; calcium channel 
and  exchanger  genes:  cacophony,  Na/Ca-exchange  protein  (calx),   
Inositol 1,4,5,-tris-phosphate receptor (Itp-r83A), and Na
+-driven anion 
exchanger 1 (Ndae1).
For mouse qPCR, RNA was extracted by TRizol method (Invitrogen) 
from individual hearts. RT-PCR was performed using the Superscript III First-
Strand Synthesis System (Invitrogen). qPCR was performed using the ABI 
7900HT system (TaqMan; Applied Biosystems), per the manufacturer’s pro-
tocols. Optimized primers from Taqman Gene Expression Array were used. 
miRNA RT was conducted using the Taqman MicroRNA Reverse Transcrip-
tion  kit  (Applied  Biosystems).  miRNA  real-time  PCR  (qRT-PCR)  was  per-
formed per the manufacturer’s protocols by using primers from Taqman 
MicroRNA Assays (Applied Biosystems). Expression levels were normal-
ized to GAPDH expression and miR-16 (microRNA qPCR).1195 Cdc42-Tin/Nkx2-5 in the heart • Qian et al.
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Houston study was not detected in any DNA samples from the 328 heart 
disease patients or in samples from 100 healthy Caucasian volunteers 
(Table II). These patient populations were recruited from St. Vincent’s Hos-
pital, Darlinghurst, the Kids Heart Research DNA Bank at The Children’s 
Hospital at Westmead, the Royal Prince Alfred Hospital, Camperdown, 
and  the  National  Australian  Childhood  Cardiomyopathy  Study.  100 
healthy Caucasian volunteers comprised a control group. All participants 
gave informed written consent and study protocols were approved by the 
relevant institutional Human Research Ethics Committees.
DNA sequencing
DNA was isolated from patient blood samples using conventional tech-
niques. Protein-coding sequences and adjacent intronic sequences of the 
CDC42 gene were amplified by polymerase chain reaction from genomic 
DNA using primers derived from intron sequences. Amplimers were puri-
fied and sequenced using the Big Dye terminator and were analyzed on a 
DNA Analyzer (ABI PRISM 3700; Applied Biosystems) at the Ramaciotti 
Centre for Gene Function Analysis (University of New South Wales, Kens-
ington, New South Wales, Australia).
Online supplemental material
Fig. S1 describes how Cdc42 interacts with Pak to regulate actin filament 
alignment and cardiac function in fly adult heart and Cdc42 does not   
interact with nmr/Tbx20 in maintaining proper heart function. Fig. S2 
shows regulation of ion channel genes dSUR and slowpoke by Cdc42 and 
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+/+;Nkx2-5
del/+,  MmCdc42
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del/+ adult mice. Fig. S4 shows additional luciferase 
assays to test regulation of Cdc42 by miR-1. Fig. S5 shows regulation of 
fly miR-1 by Tinman. Table S1 shows the cardiac arrest or fibrillation 
rate  for  deficiency  lines  covering  chromosome  X  and  part  of  chromo-
some  II.  Online  supplemental  material  is  available  at  http://www.jcb 
.org/cgi/content/full/jcb.201006114/DC1.
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